A high-throughput analysis of the IDH1(R132H) protein expression in pituitary adenomas

[1] Desideri E(2015)Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity Cancer Lett 356 217-223

[2] Vegliante R(2015)Metabolic consequences of oncogenic IDH mutations Pharmacol Ther 152 54-62

[3] Ciriolo MR(2009)Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature 462 739-744

[4] Parker SJ(2010)The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzymatic activity that converts α-ketoglutarate to 2-hydroxyglutarate Cancer Cell 17 225-234

[5] Metallo CM(2012)IDH mutation impairs histone demethylation and results in a block to cell differentiation Nature 483 474-478

[6] Dang L(2015)D-2-Hydroxyglutarate does not mimic all the IDH mutation effects, in particular the reduced etoposide triggered apoptosis mediated by an alteration in mitochondrial NADH Cell Death Dis 324 261-265

[7] White DW(2009)Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1α Science 321 1807-1812

[8] Gross S(2008)An integrated genomic analysis of human glioblastoma multiforme Science 174 1149-1153

[9] Bennett BD(2009)IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas Am J Pathol 360 765-773

[10] Bittinger MA(2009)IDH1 and IDH2 mutations in gliomas N Engl J Med 361 1058-1066

[1] Desideri E(2015)Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity Cancer Lett 356 217-223

[2] Vegliante R(2015)Metabolic consequences of oncogenic IDH mutations Pharmacol Ther 152 54-62

[3] Ciriolo MR(2009)Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature 462 739-744

[4] Parker SJ(2010)The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzymatic activity that converts α-ketoglutarate to 2-hydroxyglutarate Cancer Cell 17 225-234

[5] Metallo CM(2012)IDH mutation impairs histone demethylation and results in a block to cell differentiation Nature 483 474-478

[6] Dang L(2015)D-2-Hydroxyglutarate does not mimic all the IDH mutation effects, in particular the reduced etoposide triggered apoptosis mediated by an alteration in mitochondrial NADH Cell Death Dis 324 261-265

[7] White DW(2009)Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1α Science 321 1807-1812

[8] Gross S(2008)An integrated genomic analysis of human glioblastoma multiforme Science 174 1149-1153

[9] Bennett BD(2009)IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas Am J Pathol 360 765-773

[10] Bittinger MA(2009)IDH1 and IDH2 mutations in gliomas N Engl J Med 361 1058-1066